Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.03
(
-0.39%
)
Bitcoin
70,730.01
(
1.19%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

piggerpig

Send PM Follow Ignore
Followers 1
Posts 302
Boards Moderated 0
Alias Born 06/13/2010

piggerpig

Re: DewDiligence post# 154715

Tuesday, 01/01/2013 3:34:21 AM

Tuesday, January 01, 2013 3:34:21 AM

Post# of 257262
Actualy Uveitis is only a small portion of potential indications for the Il-1 drug Gevokizumab if it works out. Gouche being another and the CV aspect etc. In their presentations Xoma had a huge amount of slides on all the different possible indications for a succesfull Il-1 drug.
It is true however that currently only Uveitis looks realistic
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now